scispace - formally typeset
S

S.P. Lerman

Researcher at New York University

Publications -  15
Citations -  291

S.P. Lerman is an academic researcher from New York University. The author has contributed to research in topics: Spleen & Antigen. The author has an hindex of 8, co-authored 15 publications receiving 290 citations. Previous affiliations of S.P. Lerman include Kettering University.

Papers
More filters
Journal ArticleDOI

Properties of reticulum cell sarcomas in SJL/J mice. III. Promotion of tumor growth in irradiated mice by normal lymphoid cells.

TL;DR: Pretreatment of tumor recipients with macrophage inhibiting agents, such as silica, trypan blue and carrageenan, also tended to inhibit tumor growth, particularly when combined with a dose of irradiation (460 R) which by itself had only a limited effect.
Journal ArticleDOI

Properties of reticulum cell sarcomas in SJL/J mice: IV. Minimal development of cytotoxic cells despite marked proliferation to syngeneic RCS in vivo and in vitro

TL;DR: After repeated injections of X- RCS, spleen and, to a lesser degree, lymph node cells acquired the ability to give moderate secondary cytotoxic responses in vitro upon co-culture with X-RCS, which was T-cell mediated and specific for RCS although it did not distinguish between different transplantable RCS lines.
Journal ArticleDOI

Properties of reticulum cell sarcomas in SJL/J mice. II. Fate of labeled tumor cells in normal and irradiated syngeneic mice.

TL;DR: Transplantable reticulum cell sarcoma fails to grow in irradiated recipients in spite of undisturbed homing characteristics and in the absence of any evidence of cytotoxic influences from the host.
Journal ArticleDOI

Suppression of adoptive antibody responses by addition of spleen cells from agammaglobulinaemic chickens "immunised" with histocompatible bursa cells.

TL;DR: Further examination of the phenomenon of “infectious agammaglobulinaemia” in line 6 chickens, which seems to represent an ideal laboratory model for the human disease, would be greatly facilitated by a short term assay to allow better identification of the target cell.
Journal ArticleDOI

Induction of primary and inhibition of secondary antibody response to hapten by hapten conjugates of type III pneumococcal polysaccharide

TL;DR: It is suggested that a difference in avidity and/or number of anti-TNP receptors per cell between virgin and primed B cells may be an important factor in determining whether the cells will be stimulated or inhibited by exposure to hapten-SIII.